TDC
HOLX

Thompson Davis & Co’s Hologic HOLX Stock Holding History

Thompson Davis & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-176
Closed -$6K – 857
2017
Q3 		$6K Sell
176
-13
-7% -$525 0.01% 811
2017
Q2 		$9K Sell
189
-5
-3% -$221 0.01% 684
2017
Q1 		$8K Hold
194
– – 0.01% 759
2016
Q4 		$8K Buy
+194
New +$7.49K 0.01% 747
2016
Q2 		– Sell
-187
Closed -$6K – 1115
2016
Q1 		$6K Buy
187
+47
+34% +$1.64K 0.01% 743
2015
Q4 		$5K Sell
140
-257
-65% -$10K 0.01% 825
2015
Q3 		$16K Buy
397
+147
+59% +$5.83K 0.02% 531
2015
Q2 		$10K Buy
+250
New +$8.75K 0.01% 710
2014
Q3 		– Sell
-14,325
Closed -$363K – 1183
2014
Q2 		$363K Buy
+14,325
New +$335K 0.52% 41

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Thompson Davis & Co's HOLX Position: Q4 2017 in Review

Thompson Davis & Co sold out of Hologic (HOLX) in Q4 2017, closing a stake of 176 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in HOLX in Q2 2014 and held it in 9 quarters. The position peaked at $363K in Q2 2014. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • Thompson Davis & Co reported no remaining Hologic position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 176 Hologic shares in Q4 2017, an estimated $6K.
  • Thompson Davis & Co first reported a position in Hologic in Q2 2014 and held it in 9 quarters.
  • Thompson Davis & Co's Hologic position peaked at $363K in Q2 2014.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.